Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target
M. Obayed Ullah, Matthew J. Sweet, Ashley Mansell, et al.
Journal of Leukocyte Biology (2016) Vol. 100, Iss. 1, pp. 27-45
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Ubiquitination in the regulation of inflammatory cell death and cancer
Peter E. Cockram, Matthias Kist, Sumit Prakash, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 591-605
Open Access | Times Cited: 308
Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective
Yong-Sheng Zhang, Xinjie Liang, Xuefei Bao, et al.
European Journal of Medicinal Chemistry (2022) Vol. 235, pp. 114291-114291
Closed Access | Times Cited: 165
ADAR1 averts fatal type I interferon induction by ZBP1
Huipeng Jiao, Laurens Wachsmuth, Simone Wolf, et al.
Nature (2022) Vol. 607, Iss. 7920, pp. 776-783
Open Access | Times Cited: 140
Major pathways involved in macrophage polarization in cancer
Clément Kerneur, Carla E. Cano, Daniel Olive
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 139
A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications
Sahar Sedighzadeh, Amin Pastaki Khoshbin, Sepideh Razi, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 4, pp. 1889-1916
Open Access | Times Cited: 125
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
Wenxuan Ren, Lei Zhao, Ying Sun, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 42
The molecular mechanisms of signaling by cooperative assembly formation in innate immunity pathways
Parimala R. Vajjhala, Thomas Ve, Adam R. Bentham, et al.
Molecular Immunology (2017) Vol. 86, pp. 23-37
Open Access | Times Cited: 107
RIPK3 in cell death and inflammation: the good, the bad, and the ugly
Susana Orozco, Andrew Oberst
Immunological Reviews (2017) Vol. 277, Iss. 1, pp. 102-112
Open Access | Times Cited: 100
TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
Allison M. Owen, Jessica B. Fults, Naeem K. Patil, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 88
Signalling, sorting and scaffolding adaptors for Toll-like receptors
Lin Luo, Richard M. Lucas, Liping Liu, et al.
Journal of Cell Science (2019) Vol. 133, Iss. 5
Open Access | Times Cited: 86
Upregulated-gene expression of pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) via TLRs following NF-κB and MAPKs in bovine mastitis
Muhammad Faheem Akhtar, Shuai Guo, Yingfang Guo, et al.
Acta Tropica (2020) Vol. 207, pp. 105458-105458
Closed Access | Times Cited: 81
Battle Royale: Innate Recognition of Poxviruses and Viral Immune Evasion
Huibin Yu, Ryan C. Bruneau, Greg Brennan, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 765-765
Open Access | Times Cited: 77
New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention
Tiantian Li, Li Lu, Eloise Pember, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1925-1925
Open Access | Times Cited: 61
Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives
Karen Salve Coutinho‐Wolino, Patrícia Pereira Almeida, Denise Mafra, et al.
Nutrition Research (2022) Vol. 107, pp. 96-116
Open Access | Times Cited: 50
The Role of TLR2 in Infectious Diseases Caused by Mycobacteria: From Cell Biology to Therapeutic Target
Wanbin Hu, Herman P. Spaink
Biology (2022) Vol. 11, Iss. 2, pp. 246-246
Open Access | Times Cited: 48
Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity
Dariusz Szukiewicz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9818-9818
Open Access | Times Cited: 36
Toll-like receptor 4: A potential therapeutic target for multiple human diseases
Jinrui Wei, Yan Zhang, H. Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115338-115338
Open Access | Times Cited: 29
Toll-like Receptor 4 in Acute Kidney Injury
Patricia G. Vallés, Andrea Fernanda Gil Lorenzo, Rodrigo Damián García, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1415-1415
Open Access | Times Cited: 25
Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders
Irina Balan, Giorgia Boero, Samantha Lucenell Chéry, et al.
Life (2024) Vol. 14, Iss. 5, pp. 582-582
Open Access | Times Cited: 8
Structural basis for TIR domain–mediated innate immune signaling by Toll-like receptor adaptors TRIF and TRAM
M.K. Manik, Mengqi Pan, Le Xiao, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 2
Closed Access | Times Cited: 1
Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor
Douglas W. Thomson, Daniel Poeckel, Nico Zinn, et al.
ACS Medicinal Chemistry Letters (2019) Vol. 10, Iss. 5, pp. 780-785
Open Access | Times Cited: 72
Innate Immune Cells and Toll-like Receptor–Dependent Responses at the Maternal–Fetal Interface
Andrea Olmos‐Ortiz, Pilar Flores‐Espinosa, Ismael Mancilla‐Herrera, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 15, pp. 3654-3654
Open Access | Times Cited: 72
Zebrafish as a model for inflammation and drug discovery
Rodrigo Zanandrea, Carla Denise Bonan, Maria M. Campos
Drug Discovery Today (2020) Vol. 25, Iss. 12, pp. 2201-2211
Open Access | Times Cited: 66
Immune-Enhancing Effects of a Novel Glucan from Purple Sweet Potato Ipomoea batatas (L.) Lam on RAW264.7 Macrophage Cells via TLR2- and TLR4-Mediated Pathways
Chenfeng Ji, Ziyi Zhang, Jinrui Chen, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 32, pp. 9313-9325
Closed Access | Times Cited: 45
Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in LPS-challenged murine monocytes
Lynette B. Naler, Yuan-Pang Hsieh, Shuo Geng, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top